Webb, D.

(David Webb)

patient aberration trisomy group leukemia myeloid leukemia study karyotype myeloid prognostic children blood number signi trisomy 19 survival oncology erasmus mc outcome trisomy 8 cytogenetic prognostic signi ﬁcance figure analysis factor table 11 q 23/mll treatment speci 23/mll hematology cytogenetic aberrations prognostic factor result abnormality translocation trial cohort erasmu childhood university department relapse hospital research .001† chromosome myeloid leukaemia univariate analysis signi ﬁcantly balgobind value 2012. cancer library model zimmermann m partner prognostic impact volume cytogenetic abnormalities zwaan cm mll-aml blood analyses article prognostic factors trisomy 21 reference ﬁcant diagnosis ﬁcantly speci ﬁc group br j haematol 11 q 23 disease center adult ﬁcation ﬁcance coenen

1 Most Recent Publications

Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: Results of an international study (Article)
Coenen, E.A. Raimondi, S. Hasle, H. Harrison, C.J. Heerema, N.A. Kaspers, G.J. Leszl, A. Litvinko, N. Nigro, L.L. Morimoto, A. Perot, C. Auvrignon, A. Harbott, J. Reinhardt, D. Rubnitz, J.E. Smith, F.O. Stary, J. Stasevich, I. Strehl, S. Taga, T. Tomizawa, D. Webb, D. Zemanová, Z. Zimmermann, M. Alonzo, T.A. Pieters, R. Zwaan, C.M. Heuvel-Eibrink, M.M. van den Beverloo, H.B. Chang, M. Creutzig, U. Dworzak, M.N. Forestier, E. Gibson, B.

2011-06-30

Message*:
Your Email Adress*:
	*: Required fields, please provide an email address so that the RePub team can contact you if needed.